ARVO 2026 presentation: Superior efficacy of intravitreal dexamethasone implant over systemic and topical corticosteroids in a rabbit model of tnf-a–induced uveitis
Ocular uveitis is a major cause of vision loss and often requires corticosteroid therapy to control inflammation. Intravitreal administration of tumor necrosis factor alpha (TNF-α) in rabbit eyes causes ocular inflammation in the anterior chamber, iris hyperemia, and vitreal haze. The purpose of this study was to compare the anti-inflammatory efficacy of intravitreal Ozurdex, systemic prednisolone, and topical dexamethasone.
Learn more
